The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease
- PMID: 25628064
- PMCID: PMC4361273
- DOI: 10.1111/jnc.13033
The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease
Abstract
Peptidyl-prolyl cis/trans isomerases (PPIases), a unique family of molecular chaperones, regulate protein folding at proline residues. These residues are abundant within intrinsically disordered proteins, like the microtubule-associated protein tau. Tau has been shown to become hyperphosphorylated and accumulate as one of the two main pathological hallmarks in Alzheimer's disease, the other being amyloid beta (Ab). PPIases, including Pin1, FK506-binding protein (FKBP) 52, FKBP51, and FKBP12, have been shown to interact with and regulate tau biology. This interaction is particularly important given the numerous proline-directed phosphorylation sites found on tau and the role phosphorylation has been found to play in pathogenesis. This regulation then affects downstream aggregation and oligomerization of tau. However, many PPIases have yet to be explored for their effects on tau biology, despite the high likelihood of interaction based on proline content. Moreover, Pin1, FKBP12, FKBP52, cyclophilin (Cyp) A, CypB, and CypD have been shown to also regulate Ab production or the toxicity associated with Ab pathology. Therefore, PPIases directly and indirectly regulate pathogenic protein multimerization in Alzheimer's disease and represent a family rich in targets for modulating the accumulation and toxicity.
Keywords: Alzheimer's disease; PPIase; amyloid β; chaperone; immunophilin; tau.
© 2015 International Society for Neurochemistry.
Figures

Similar articles
-
Bending tau into shape: the emerging role of peptidyl-prolyl isomerases in tauopathies.Mol Neurobiol. 2011 Aug;44(1):65-70. doi: 10.1007/s12035-011-8182-4. Epub 2011 Apr 28. Mol Neurobiol. 2011. PMID: 21523562 Free PMC article. Review.
-
The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.Nature. 2006 Mar 23;440(7083):528-34. doi: 10.1038/nature04543. Nature. 2006. PMID: 16554819
-
Regulation of tau by peptidyl-prolyl isomerases.Curr Opin Struct Biol. 2024 Feb;84:102739. doi: 10.1016/j.sbi.2023.102739. Epub 2023 Dec 7. Curr Opin Struct Biol. 2024. PMID: 38061261 Review.
-
FKBP immunophilins and Alzheimer's disease: a chaperoned affair.J Biosci. 2011 Aug;36(3):493-8. doi: 10.1007/s12038-011-9080-7. J Biosci. 2011. PMID: 21799260 Review.
-
Granular expression of prolyl-peptidyl isomerase PIN1 is a constant and specific feature of Alzheimer's disease pathology and is independent of tau, Aβ and TDP-43 pathology.Acta Neuropathol. 2011 May;121(5):635-49. doi: 10.1007/s00401-011-0798-y. Epub 2011 Jan 18. Acta Neuropathol. 2011. PMID: 21243369 Free PMC article.
Cited by
-
Circulating proteomic biomarkers for diagnosing sporadic amyotrophic lateral sclerosis: a cross-sectional study.Neural Regen Res. 2024 Aug 1;19(8):1842-1848. doi: 10.4103/1673-5374.389357. Epub 2023 Nov 8. Neural Regen Res. 2024. PMID: 38103252 Free PMC article.
-
Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels.Autophagy. 2021 Dec;17(12):4119-4140. doi: 10.1080/15548627.2021.1904489. Epub 2021 May 24. Autophagy. 2021. PMID: 34024231 Free PMC article.
-
Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases.Curr Alzheimer Res. 2022;19(7):511-522. doi: 10.2174/1567205019666220805120303. Curr Alzheimer Res. 2022. PMID: 35929619 Free PMC article.
-
Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development.Front Neurosci. 2019 Jan 10;12:1017. doi: 10.3389/fnins.2018.01017. eCollection 2018. Front Neurosci. 2019. PMID: 30686983 Free PMC article. Review.
-
Hsp90-Associated Immunophilin Homolog Cpr7 Is Required for the Mitotic Stability of [URE3] Prion in Saccharomyces cerevisiae.PLoS Genet. 2015 Oct 16;11(10):e1005567. doi: 10.1371/journal.pgen.1005567. eCollection 2015 Oct. PLoS Genet. 2015. PMID: 26473735 Free PMC article.
References
-
- Ahn J, Murphy M, Kratowicz S, Wang A, Levine AJ, George DL. Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene. 1999;18:5954–5958. - PubMed
-
- Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta neuropathologica. 2002;103:26–35. - PubMed
-
- Bai X, Ma D, Liu A, Shen X, Wang QJ, Liu Y, Jiang Y. Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science. 2007;318:977–980. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous